Navigation Links
New drug helps allergies

The new drug Clarinex is coming on the market with an advertising blitz--but no proof it works better than older allergy drugs. "Billions of seasonal allergies, one tiny blue pill," proclaim ads from //manufacturer Schering-Plough Corp.

Schering-Plough makes Claritin, the nation's best-selling prescription allergy drug. In November, the Food and Drug Administration is expected to switch Claritin to over-the-counter drug. A month's supply, which now costs about $85, could drop to about $15. Moreover, Schering-Plough's Claritin patent is expected to expire in April, enabling competitors to sell generic versions for even less than $15.

Clarinex is a slightly altered form of Claritin. Within one hour of taking Claritin, the body turns its active ingredient, loratadine, into the active ingredient of Clarinex, desloratadine. Claritin works for between 18 hours and 24 hours. Indeed, Claritin's recommended dose is one pill a day.

With Claritin's $2.8 billion in sales expected to plummet, Schering-Plough is trying to switch patients to Clarinex. In addition to running television, print and Internet ads, the company is selling Clarinex at 20% less than Claritin's price. In order to get Clarinex approved by the FDA, Schering-Plough needed only to prove the drug works better than a placebo, or sugar pill.
'"/>




Page: 1

Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. Patient’s perception of health status helps in better recover
3. New vaccine helps allergy and asthma patients
4. New vaccine helps allergy and asthma patients
5. Now umbilical cord helps in stroke treatment.
6. Spirituality helps lessen arthritic pain
7. New drug helps boost cancer treatment
8. Supplement helps cardiac surgery
9. Antidepressant helps obesity
10. Dopamine helps stroke survivors
11. Radiotherapy helps in colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... ... readers, this installment is bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities ... within the industry, from leading advocates, associations and industry leaders such as Bioness. ...
(Date:5/27/2016)... ... May 27, 2016 , ... Each year Standard Process ... Outerbridge is this year’s Life University winner of a $2,500 scholarship ... Student Leadership Awards ceremony. , Outerbridge is approaching her last quarter at Life ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot ... of defective respirators, according to court documents and SEC filings. A jury ... Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... The ... Project offering a new model of care for living and healing, celebrated its ... values: Meaningful Life in a Real Home provided by Empowered Staff. , “This is ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will present ... Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public Library. ... Retina Group of New York , is a Board Certified ophthalmologist who completed ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Celsion Corporation (NASDAQ: ... company, today provided an update on its ongoing ... trial combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... GEN-1 is an IL-12 DNA plasmid vector formulated ...
(Date:5/24/2016)... May 24, 2016 The ... world , s first dual therapy stent, ...   OrbusNeich, a global company specializing in ... portfolio to include products to treat peripheral artery disease. ... first entry devices for lower limb and arteriovenous (AV) ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse à ... destinés à l,intervention portant sur les membres ... OrbusNeich, entreprise mondiale spécialisée dans ... changer la vie, a élargi son portefeuille ...
Breaking Medicine Technology: